Top Tech Companies (720)
Don't see your company?
Create a company profile
Interius is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next-generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of Pennsylvania.
As a specialized company dedicated to ophthalmology, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and medical devices. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan and its products now reach patients in over 60 countries. With scientific knowledge and organizational capabilities nurtured over a 130-year history, Santen provides products and services to contribute to the well-being of patients, their loved ones and consequently to society. Santen Pharmaceutical Official Social Media Global Terms of Use https://www.santen.com/en/legal
We all know someone who's been in the hospital -- a parent, spouse, child, neighbor, coworker or friend. Safecor Health helps hospitals ensure quality and patient safety through superior packaging and bar coding services. Safecor Health is the industry leader committed to providing institutional pharmacists with unit-dose repackaging services that allow them to outsource the challenging and time-consuming tasks of packaging. Operating out of two state-of-the-art, FDA-registered facilities, Safecor Health helps pharmacies develop a comprehensive unit-dose packaging strategy. Repackaging services include: - Unit-dose oral solids - Liquid unit-dose cups - Oral syringes - Robot-compatible packaging - Controlled substance packaging - Hazardous drug packaging - Bar coding and labeling Safecor Health's services provide significant cost savings and operational efficiency to more than 1,000 hospitals and health systems nationwide, all while improving quality, patient care and medication safety. Learn more at safecorhealth.com.
Molecular Stethoscope, Inc., a San Diego, CA-based biotechnology company developing novel blood-based early detection.
Catalent Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent supports our partners in introducing 200 new products and manufacturing over 70 billion doses each year. Since becoming a publicly traded company in 2014, we have grown to become a community of approximately 19,000+ workers who support over 7,000 products for over 1,000 customers around the world. We share a common goal: to put patients first and help people around the world live better and healthier lives. Catalyst + Talent. Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. We have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging results. more products. better treatments. reliably supplied.™ Your talents, ideas, and passion are essential to our mission: to develop, manufacture, and supply products that help people live better, healthier lives. Join us! Catalent hires people with a passion to make a difference to the health of millions of people globally. Your expertise, coupled with Catalent’s advanced technologies and collaboration with thousands of innovative pharmaceutical, biotech, and healthcare companies, will help bring life-enhancing products to life. Grow with us. Be challenged. Make a personal impact. Visit https://careers.catalent.com/us/en to explore career opportunities
LENUS BIOSCIENCE SPAC targets to acquire a conglomerate of companies in the area of medical cannabis CBD)
Sebela Pharmaceuticals Inc. is committed to improving patients’ lives by developing, marketing and selling differentiated branded prescription pharmaceuticals that bring meaningful value to patients affected by gastrointestinal, dermatological and women’s health diseases. To fulfill our commitment to improving patient’s lives, we are continuing to grow our US commercial infrastructure, marketed product portfolio and late stage development pipeline in our core therapeutic areas. Our growth strategy includes in-licensing and acquiring late-stage drug candidates and marketed products that utilize and enhance our existing development and commercial capabilities. Sebela operates from two locations with an office in Roswell, Georgia, and headquarters in Dublin, Ireland.
Medical jobs for medical experts. On-demand physician-only consulting marketplace. Source and secure physician talent within your budget.
Headquartered in Dedham, Mass., AliMed is a specialty medical supplies manufacturer and distributor with on-site customization capabilities and a vast portfolio of healthcare products designed to improve patient outcomes and experiences. Celebrating 50 years of serving patient needs spanning “hospital to home,” AliMed has built its long history and strong reputation on responsiveness, exceptional customer service, and high-quality offerings. Visit AliMed.com for more information. Rehabilitation • Orthopedics • Skilled Nursing • Operating Room • Medical Imaging
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at www.boehringer-ingelheim.com
.jpeg)
.png)
Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinson’s, Alzheimer’s, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.
Pulmotect develops products that boost the innate immune system to protect against a wide range of lung infections.
Summit Biosciences is developing, manufacturing & commercializing generic and innovative nasal spray drug products.
Continuous Precision Medicine™ is a leader in the fight against the opioid epidemic.
Alfasigma USA is the local affiliate of the Italian based pharmaceutical company, Alfasigma. The company was formed in 2015 as a result of the merger between two historic Italian pharmaceutical companies, Alfa Wassermann and Sigma-Tau. Alfasigma is a leading Italian pharmaceutical company focused on prescription drugs, over-the counter (OTC) and nutraceutical products and has a presence in 90 countries. Alfasigma USA’s main goals are to improve the health and quality of life of patients by finding solutions to treat specific patient populations, expand our existing portfolio and bring new products into the US market. We strive to be a strong healthy company in a strong healthy world. Alfasigma USA is headquartered in Covington, LA., has a manufacturing plant in Shreveport, LA., a mail order pharmacy call center in the Covington location and an established national salesforce. In addition, a commercial operations hub opened in 2018. Alfasigma USA, Inc. distributes a portfolio of prescription products, both traditional and nutritional, to help individuals who are suffering from GI disorders, major depressive disorder, diabetic peripheral neuropathy and mild cognitive impairment. Through the company’s commitment to improving patients’ health and quality of life, Alfasigma USA, Inc. strives to provide innovative solutions that respond to the needs of a changing society. Discover Alfasigma USA at http://www.alfasigmausa.com.
When you donate blood plasma, you help create life-changing medicines, while putting a little extra money in your pocket at the same time.
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
SpotRx is a full-service pharmacy designed around our patients' needs. We leverage innovative technology to create one of a kind services that take patient care to a new level. We are focused on providing; greater medication access, competitive medication pricing, and real-time access to a pharmacist. SpotRx’s parent company, MedAvail Technologies Inc., has a proven track record as a healthcare technology company that has developed and commercialized the innovative self-service pharmacy, mobile app, kiosk and drive-thru solution SpotRx utilizes to provide you with unparalleled availability to the medications you need.
Verve Therapeutics is a clinical-stage biotechnology company created with a singular focus: to protect the world from heart disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease. Verve’s gene editing medicines are designed to safely edit the genome of adults and mimic naturally occurring gene variants to permanently lower LDL cholesterol and triglyceride levels. The company is advancing a pipeline of precision genetic medicines, led by VERVE-101, which is being developed initially for heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease. In 2023, Verve was recognized as a "Best Places to Work" by the Boston Globe. Verve is headquartered in Boston, Massachusetts
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
